AXIM® Biotechnologies, Inc. Secures Funding to Continue Pharmaceutical Clinical Trials Program in Cannabinoid Research and Development for Multiple Indications
26. Oktober 2016 09:00 ET
|
AXIM Biotechnologies, Inc
NEW YORK, Oct. 26, 2016 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that the Company has...
AXIM Biotech Begins Human Clinical Trials With Cannabigerol (CBG) for Psoriasis and Eczema in Patients
17. Mai 2016 09:00 ET
|
AXIM BIOTECHNOLOGIES, INC
NEW YORK, May 17, 2016 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTC:AXIM) is pleased to announce to shareholders and the public that the Company is launching human dermatological clinical...
Medical Marijuana, Inc. Investment – AXIM Biotech – Lays Out Powerhouse IP Pipeline, Cannabinoid R&D in Interview
25. Februar 2016 09:00 ET
|
Medical Marijuana Inc
SAN DIEGO, Feb. 25, 2016 (GLOBE NEWSWIRE) -- Medical Marijuana, Inc. (OTC Pink:MJNA) is proud to announce to the public and its shareholders that its portfolio investment, AXIM® Biotechnologies,...
AXIM Biotech Leads Cannabis Industry in Cannabinoid Research, Development and Intellectual Property; Tackles 15 Debilitating Conditions With No Known Cure
18. Februar 2016 09:00 ET
|
AXIM BIOTECHNOLOGIES, INC
NEW YORK, Feb. 18, 2016 (GLOBE NEWSWIRE) -- Dr. George E. Anastassov, MD, DDS, MBA and Chief Executive Officer of AXIM® Biotechnologies, Inc. (OTC:AXIM) shares the hemp innovator’s vision and...
Photo Release -- AXIM Biotech Announces Hemp Innovations for Life Sciences
04. Juni 2015 09:00 ET
|
AXIM BIOTECHNOLOGIES, INC
SAN DIEGO, June 4, 2015 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (OTC:AXIM) is a unique biotechnology corporation with a focus on global research, development and production of pharmaceutical,...
Photo Release -- AXIM Biotech Garners Global Headlines After Announcing First-Ever Lines of Cannabigerol (CBG) Products
20. April 2015 15:12 ET
|
AXIM BIOTECHNOLOGIES, INC
NEW YORK, April 20, 2015 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (OTC:AXIM), is pleased to announce that the company's innovative new hemp-based cannabigerol (CBG) product lines were covered in...
Photo Release -- Dr. Jacques F. Meis, World-Renowned Infectious Disease Specialist, Joins AXIM Biotechnologies, Inc.'s Advisory Board
18. März 2015 12:31 ET
|
AXIM BIOTECHNOLOGIES, INC
NEW YORK, March 18, 2015 (GLOBE NEWSWIRE) -- AXIM Biotechnologies (OTC:AXIM), an industrial hemp biosciences industry leader, welcomes Dr. Jacques F. Meis, MD, PhD, world-renowned infectious disease...
Photo Release -- AXIM Biotech Unveils World's First Hemp Cannabigerol (CBG) Oral Care & Cosmetic Products
05. März 2015 09:00 ET
|
AXIM BIOTECHNOLOGIES, INC
NEW YORK, March 5, 2015 (GLOBE NEWSWIRE) -- New York-based AXIM Biotechnologies, Inc. (OTC:AXIM) proudly presented its line of the world's first oral care and cosmetic products that include...
AXIM Biotechnologies, Inc. Announces Cosmetics Division
19. Februar 2015 09:00 ET
|
AXIM BIOTECHNOLOGIES, INC
NEW YORK, Feb. 19, 2015 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (OTC:AXIM), an industry leader in cannabinoid research and industrial hemp product development, is proud to announce that it has...